Fundraising Fox

Embera NeuroTherapeutics, Inc.

Sudbury, US · Delaware corporation · 1 known investors

Developing EMB-001, a medication treating addiction by targeting the stress activity and response system in the patient's body.

Founders & leadership

RB
Robert B. LinkeExecutive

Board

RB
Ross BarrettBoard director
FH
Franz HeftiBoard director
JB
John BeairdBoard director
JL
Joseph LovettBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$10.6M disclosed across 2 rounds · 2014–2019

$6.1MraisedDec 2019 · 70 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert B. LinkeExecutive Officer, Director
  • Joseph LovettDirector
  • John BeairdDirector
  • Ross BarrettDirector
Offering amount
$8.3M
Amount sold
$6.1M
Sales commissions
$3K
Placement agents
Witherspoon Partners
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$4.5MraisedSep 2015 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ross BarrettDirector
  • Franz HeftiDirector
  • John BeairdDirector
  • Robert B. LinkeExecutive Officer, Director
  • Joseph LovettDirector
Offering amount
$6.6M
Amount sold
$4.5M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Embera NeuroTherapeutics, Inc. do?
Developing EMB-001, a medication treating addiction by targeting the stress activity and response system in the patient's body.
Who are Embera NeuroTherapeutics, Inc.'s investors?
Embera NeuroTherapeutics, Inc.'s investors include Innovation Catalyst.
How much funding has Embera NeuroTherapeutics, Inc. raised?
Embera NeuroTherapeutics, Inc. has disclosed $10.6M raised across 2 rounds.
Where is Embera NeuroTherapeutics, Inc. headquartered?
Embera NeuroTherapeutics, Inc. is headquartered in Sudbury, US.